American Century Companies’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
Other funds holding OREX
BG
FCMI
SC
BFA
NMC
BIT
American Century Companies's OREX Position: Q1 2016 in Review
American Century Companies sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2016, closing a stake of 41,804 shares — an estimated $719K sold.
American Century Companies first reported a position in OREX in Q2 2014 and held it in 4 quarters. The position peaked at $2.11M in Q2 2015. 104 funds tracked by Wall St. Rank hold OREX as of Q1 2016.
- American Century Companies reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
- American Century Companies sold 41,804 Orexigen Therapeutics, Inc. shares in Q1 2016, an estimated $719K.
- American Century Companies first reported a position in Orexigen Therapeutics, Inc. in Q2 2014 and held it in 4 quarters.
- American Century Companies's Orexigen Therapeutics, Inc. position peaked at $2.11M in Q2 2015.
- 104 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2016.
Based on American Century Companies's 13F filing for Q1 2016, filed 2 May 2016.